Illuminate has unique access to data on pricing of pharmaceuticals and risk sharing arrangements through our RED data base. Illuminate has extensive expertise into the pricing of pharmaceuticals, diagnostic tests and devices into reimbursed and private markets. Illuminate provides advice on the best pricing options to successfully list products employing our experience and analysis. In the private market we have run Discrete Choice Experiments to identify the likely trade off between price and sales.
Illuminate prepares special reports for companies on risk sharing arrangements. We have also developed sophisticated models which estimate projected prices for pharmaceuticals listed on the PBS as part of industry legal cases and for the commercial operations of pharmaceutical companies.